Clinical Trial Update: Melatonin as Adjuvant Therapy in Breast Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates a Phase 2/Phase 3 study of melatonin as adjuvant therapy in patients with breast cancer, with the current status listed as UNK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Khon Kaen University | Conditions: Stage II and III Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN